Institutional & Market Access Partnerships

International Pharmaceutical Market Access for High-Growth Healthcare Markets

Hospital portfolios, differentiated formulations and consumer health partnerships across MENA, Selected African Markets and LATAM.

What we offer
Manufacturing Access
Direct access to established EU GMP-compliant manufacturing partners with export-ready product portfolios.
Distributor & Market Development
Structured market entry through established distributor networks and commercial execution.
Portfolio Strategy
Execution of tailored portfolios across OTC, hospital, oncology and specialty categories.
About PharmaLink

A Business Development Platform for International Pharmaceutical Growth

PharmaLink Iberia is an execution-driven pharmaceutical partnership platform supporting international commercialization, manufacturer-to-market coordination, go-to-market execution and structured market development across Europe, MENA, selected African markets and LATAM.

EU Manufacturing Base

Reliable European manufacturing capabilities and quality standards.

Commercial Alignment

Support in matching products, markets and qualified local partners.

Long-Term Development

Partnerships designed for continuity, scalability and sustainable growth.

Headquarters
Madrid, Spain

A European hub for international pharmaceutical partnerships, commercial coordination and market development.

Manufacturing Network

Selected European Manufacturing Capabilities

PharmaLink works with selected European pharmaceutical manufacturers operating under high GMP standards and prepared for international commercial development.

Representative Partner
Farmalider

Farmalider illustrates the type of European manufacturing partner PharmaLink works with: strong pharmaceutical capabilities, broad therapeutic coverage and export readiness for international distribution.

EU GMP & Pharmaceutical Quality Frameworks

Manufacturing under EU GMP standards and alignment with EU pharmaceutical quality and compliance frameworks for international markets.

Advanced R&D

Continuous innovation in pharmaceutical formulation.

Broad Portfolio

OTC, dental, hospital, cough & cold and specialty products.

Export Ready

Optimized supply chain for international distribution.

Hospital & Specialty Network

Additional European manufacturing collaborations across oncology, injectables, biosimilars and specialty hospital products.

  • Oncology & hospital injectables
  • Medical devices & consumables
  • Institutional healthcare supply partnerships
Execution Model

From Product to Market Execution

PharmaLink enables structured market entry through regulatory readiness, commercial execution and end-to-end delivery.

Marketing Authorizations (MA)

Access to European marketing authorizations supporting international expansion strategies.

CPP-Based Export Strategy

Structured export models based on Certificates of Pharmaceutical Product (CPP).

Regulatory Documentation

Preparation of compliant documentation aligned with market-specific regulatory requirements.

Pricing & Commercial Structuring

Flexible pricing models and commercial structures adapted to each market.

End-to-End Execution

From manufacturer to final customer, ensuring continuity and operational execution.

Market Entry Strategy

Structured entry into complex markets through local partnerships and execution models.

We don't advise. We execute.

PharmaLink provides direct access to pharmaceutical products, regulatory pathways and end-to-end execution from manufacturer to market.

Representative Manufacturing Strength

Proven Scale Across Global Markets

Through selected European manufacturing partnerships, PharmaLink provides access to strong industrial capabilities and international market reach.

58+
Countries
335+
Registrations
17
Patent Families
Institutional & Specialty Portfolios

Specialty Healthcare & Market Access Capabilities

Institutional healthcare portfolios, specialty biosimilars, differentiated formulations and scalable pharmaceutical partnerships across high-growth international markets.

OTC

OTC Products

Consumer healthcare products for pharmacy channels.

Typical formats

Tablets Capsules Granules Sticks Sachets Effervescents
Dental

Dental Care

Professional oral healthcare and dental solutions, including dental anesthetics.

Typical formats

Cartridges Injectables Solutions Gels
Hospital

Hospital Medicines

Injectables and institutional therapeutic products for hospital channels.

Typical formats

Vials Ampoules Pre-filled syringes Lyophilized
Respiratory

Cough & Cold

Respiratory care formats for seasonal and year-round needs.

Typical formats

Sachets Granules Sticks Syrups Solutions Effervescents
Oncology

Oncology & Hospital Therapies

Institutional oncology therapies, injectable treatments and hospital-focused pharmaceutical solutions.

Representative presentations

Vials Lyophilized Injectables Infusion
Biosimilars

Biosimilars & Specialty Care

Biosimilar products and specialty therapies aligned with regulated market access pathways.

Global Markets

Priority Markets

PharmaLink prioritizes international markets with growing demand for trusted European pharmaceutical products.

Interconnected footprint
Madrid as a hub for international partner development
Madrid Iraq UAE Kuwait Saudi Arabia Jordan Lebanon Egypt South Africa C么te d鈥橧voire Guinea-Bis谩u Mexico Argentina

Middle East

  • Iraq
  • UAE
  • Kuwait
  • Saudi Arabia
  • Jordan
  • Lebanon

Africa

  • Egypt
  • South Africa
  • C么te d鈥橧voire
  • Guinea-Bis谩u

Latin America

  • Mexico
  • Argentina
Why PharmaLink

A Clear Value Proposition

European manufacturing credibility combined with commercial alignment in international markets.

Manufacturing Access

Trusted access to selected European pharmaceutical manufacturing partners.

Qualified Partner Alignment

Connection with qualified local partners and healthcare stakeholders.

Market Understanding

Practical understanding of entry routes, positioning and opportunity development.

Flexible Execution

Collaboration models adapted to manufacturers, distributors and commercial goals.

Partnership Model

How We Work

A simple model focused on identifying opportunity, aligning counterparties and supporting execution.

1

Identify

Assess products, market priorities and commercial fit.

2

Align

Connect manufacturers with relevant distributors and local stakeholders.

3

Develop

Support commercial follow-up, execution and long-term growth.

Get In Touch

Let鈥檚 Build Something Together

Whether you are a pharmaceutical manufacturer seeking international expansion or a distributor looking for quality European products, we would love to hear from you.

Office
PharmaLink Iberia S.L., Madrid, Spain
Email
info@pharmalinkiberia.com
Phone
+34 609 112 943

Submitting this form opens your default email client and prepares a message to PharmaLink.